NetworkNewsBreaks

WednesdayMar 20, 2024 3:45 pm

NetworkNewsBreaks – Why Zoned Properties Inc. (ZDPY) Is ‘One to Watch’

Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company for emerging and highly regulated industries, is focused on acquiring value-add real estate within the U.S. regulated cannabis industry. “The company aspires to innovate, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers. The company is redefining the approach to commercial real estate investment through its standardized process backed by its proprietary property technology. Zoned Properties has developed a national ecosystem of real estate services to support its real estate development process, including a commercial real estate brokerage and a real estate advisory practice… The company targets commercial…

Continue Reading

WednesdayMar 20, 2024 3:01 pm

NetworkNewsBreaks – GEMXX Corp. (GEMZ) Laying Foundation for Sustainable Long-Term Growth

GEMXX (OTC: GEMZ), a mining and jewelry-making company, specializes in the mining of ammolite, a rare, opal-like gemstone that is only found on the eastern slopes of the Rocky Mountains in Southern Alberta. Last year, the company expanded into the mining of gold to complement the historical resources that undergird its jewelry production strategy. “On Feb. 13, the company reported product deliveries worth $1,051,374 at retail for the month of January, highlighting the success of GEMXX’s focus on operational efficiency and production of high-margin products… GEMXX plans to build on the year-opening report with further investments in exploration, drilling, surveys,…

Continue Reading

WednesdayMar 20, 2024 2:43 pm

NetworkNewsBreaks – Authentic Holdings Inc. (OTC: AHRO) Appoints Merchandising Expert, Former SONY SVP to Advisory Board

Authentic Holdings (OTC: AHRO), and its subsidiary, Authentic Heroes, a distinctive new merchandising company, have announced a new member of its advisory board: Howard Lau. A former senior vice president from Sony, Lau was head of Sony Music’s artist merchandising company, overseeing its growth into a global merchandising powerhouse. In that position, he managed all NIL rights acquisitions and management, design, e-commerce, retail sales, tour merchandising, licensing and artist relations. Prior to working at Sony, Lau served in other business and leadership positions, working to secure some of the biggest and most important music and merchandising rights deals in the industry.…

Continue Reading

WednesdayMar 20, 2024 1:35 pm

NetworkNewsBreaks – PaxMedica Inc. (NASDAQ: PXMD) on Promising Path to Meet Medical Needs of ASD Patients

PaxMedica (NASDAQ: PXMD), a clinical-stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (“APTs”), is focusing its lead program on autism spectrum disorder (“ASD”), for which there is no approved pharmacologic treatment targeting cause and symptoms. “The current ASD treatments only address the symptoms of the condition but do not target the pathophysiology itself. PaxMedica is on a promising path to address the unmet medical needs of families with ASD – bringing hope to millions,” a recent article reads. “PaxMedica is using existing research on a drug called suramin, initially created to treat a disease called Human African…

Continue Reading

WednesdayMar 20, 2024 1:19 pm

NetworkNewsBreaks – Sustain SoCal to Showcase Intersection of Innovation and Sustainability at Upcoming Event

Sustain Southern California (“Sustain SoCal”) today announced plans to host the Building Sustainable Communities conference slated to take place at The Cove at UCI Beall Applied Innovation in Irvine, California, on Thursday, April 4, 2024. The demand for intelligent eco-conscious solutions has become increasingly urgent amid increased global population and urbanization. This one-of-a-kind conference is where innovation meets sustainability. “Over the past century, and particularly the last two decades, urbanization has surged at an unprecedented pace. While cities are vital for access to housing, employment, infrastructure, and essential services, unchecked development exacts a heavy toll, evidenced by the escalating threats…

Continue Reading

WednesdayMar 20, 2024 1:12 pm

NetworkNewsBreaks – Software Effective Solutions Corp.’s (SFWJ) Eko2o S.A.S Eyes Expansion into Costa Rica and Central America

Eko2o S.A.S., a leader in sustainable agricultural technologies and a majority-owned subsidiary of Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), today announced its strategic plans to expand operations into Costa Rica and the broader Central American market. The initiative aligns with Eko2o’s mission to promote sustainable agriculture and innovative technology solutions around the globe. “Costa Rica and Central America are regions known for their commitment to environmental sustainability and high agricultural potential. This makes them the perfect match for Eko2o’s mission and expertise,” said Juan Ricardo Velez, CEO of Eko2o. “We are excited about the opportunity to collaborate with local…

Continue Reading

WednesdayMar 20, 2024 1:05 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Announces Leading PR Firm as Official Communications and Marketing Agency of Record

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a leading green ammonia company, has selected Counsel Public Affairs as its communications and marketing agency of record; the two companies entered into an initial 12-month agreement. According to the announcement, FuelPositive conducted a thorough search and selected Counsel for its reputation as Canada’s most effective public affairs firm and because of its specialization in government relations, strategic communications and integrated campaigns. In addition to PR support, Counsel will provide investor relations communications support. “We are thrilled to welcome Counsel Public Affairs as our newly appointed agency of record,” said FuelPositive chief impact officer Luna…

Continue Reading

WednesdayMar 20, 2024 12:58 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at a combined price of $4.215 per share of common stock (or per prefunded warrant in lieu thereof) and accompanying warrant. Genprex will be receive approximately $6.5 million in gross proceeds from the offering, before standard fees and…

Continue Reading

WednesdayMar 20, 2024 12:32 pm

NetworkNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class A common stock will begin trading on the NASDAQ Capital Market on a split-adjusted basis. “The reverse split is intended to increase the per share trading price of the company’s common stock to enable the…

Continue Reading

WednesdayMar 20, 2024 12:23 pm

NetworkNewsBreaks – Sigyn Therapeutics Inc. (SIGY) Developing Innovative Technologies to Address Critical Healthcare Challenges

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, recently expanded its therapeutic candidates, introducing ImmunePrep(TM) to improve the delivery of immunotherapeutic antibodies to treat cancer. “The company is also developing ChemoPrep(TM) and ChemoPure(TM) to optimize chemotherapy delivery and reduce treatment toxicity. The company further disclosed that clinical site locations for first-in-human studies for Sigyn Therapy(TM) have been identified. Sigyn Therapy(TM) is a novel blood purification technology to treat pathogen-associated conditions that are beyond the reach of drugs,” a recent article reads. “Sigyn Therapeutics is developing innovative medical technologies to address critical healthcare challenges. The company’s technologies show promise in…

Continue Reading